Nuala Moran

UK Officials Weigh Benefits, Costs Of Growing GM Crops

July 16, 2003

UK Consolidation Continues As British Biotech, Vernalis Merging

July 9, 2003

LONDON - UK biotechnology reached the end of an era last week with the announcement that British Biotech plc will take over Vernalis plc in an agreed-to £48 million (US$79.7 million) deal, ditching the British Biotech moniker and closing the company's facility in Oxford. (BioWorld International)

CeNeS Moving To Alternative Exchange As Market Cap Dips

July 9, 2003

By Nuala Moran

Xenova Touts New Class Of Cancer Agents, Starts Phase I

July 9, 2003

By Nuala Moran

UK Consolidation Continues As British Biotech, Vernalis Merging

July 9, 2003

By Nuala Moran

LONDON - UK biotechnology reached the end of an era last week with the announcement that British Biotech plc will take over Vernalis plc in an agreed-to £48 million (US$79.7 million) deal, ditching the British Biotech moniker and closing the company's facility in Oxford. (BioWorld International)

Xenova Touts New Class Of Cancer Agents, Starts Phase I

July 9, 2003

By Nuala Moran

CeNeS Moving To Alternative Exchange As Market Cap Dips

July 9, 2003

By Nuala Moran

UK Consolidation Continues As British Biotech, Vernalis Merging

July 7, 2003

By Nuala Moran

LONDON - Consolidation of UK biotechnology continues apace with the announcement that British Biotech plc will take over Vernalis plc in a £48 million (US$79.7 million) all-share deal that comes just three months after British Biotech's takeover of RiboTargets Holdings plc. (BioWorld Today)

UK Consolidation Continues As British Biotech, Vernalis Merging

July 7, 2003

By Nuala Moran

LONDON - Consolidation of UK biotechnology continues apace with the announcement that British Biotech plc will take over Vernalis plc in a £48 million (US$79.7 million) all-share deal that comes just three months after British Biotech's takeover of RiboTargets Holdings plc. (BioWorld Today)